Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

IceCure Medical has regained compliance with Nasdaq’s minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. This milestone indicates the company’s stabilized ...

IceCure Medical’s next-generation cryoablation technology to receive European patent: Caesarea, Israel Monday, January 6, 2025, 13:00 Hrs [IST] IceCure Medical Ltd., a developer ...

XSense system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure CAESAREA ...

Icecure Medical ( ) has issued an update. IceCure Medical has received an Intention to Grant Notice from the European Patent Office for its innovative cryogenic system connector t ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

WTOP spoke with people heading into a Silver Spring, Maryland, gym for their morning workouts, to hear more about what they ...

INR:0767. ekbet registration Chinese scientists reveal the cryo-EM structure of the NSD protein family and the nucleosome complex Roche's antibody cocktail the ...

Upgrade and update your skincare routine with beauty gadgets that deliver results as impressive as they feel As the new year approaches, there’s no better time to refine your ...

Professor Sangmin Lee from POSTECH’s Department of Chemical Engineering, in collaboration with 2024 Nobel Chemistry Laureate Professor David Baker from the University of Washington, has developed an ...

Tyler Perry reminds us that starting therapy is never too late. The director was recently a guest on The View and revealed that he began therapy for the first time at 54. Perry said a question ...

The POLARx cryoablation system. [Image courtesy of Boston Scientific] The FDA issued a notice alerting customers to updates made by Boston Scientific (NYSE: BSX) + to its PolarX cryoablation ...